Goliath Film & Media Holdings — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Goliath Film & Media Holdings filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Apr 30, 2017 | $250.0K | Aug 13, 2018 |
| FY2017 | Apr 30, 2016 | $175.0K | Aug 15, 2017 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $32.7K | Jul 29, 2025 |
| FY2025 | Apr 30, 2024 | $47.7K | Jul 29, 2025 |
| FY2024 | Apr 30, 2023 | $121.6K | Aug 13, 2024 |
| FY2022 | Apr 30, 2022 | $0 | Jul 29, 2022 |
| FY2022 | Apr 30, 2021 | $38.4K | Jul 29, 2022 |
| FY2021 | Apr 30, 2020 | $14.0K | Jul 29, 2021 |
| FY2020 | Apr 30, 2019 | $13.7K | Aug 13, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $32.7K | Jul 29, 2025 |
| FY2025 | Apr 30, 2024 | $47.7K | Jul 29, 2025 |
| FY2024 | Apr 30, 2023 | $121.6K | Aug 13, 2024 |
| FY2022 | Apr 30, 2021 | $38.4K | Jul 29, 2022 |
| FY2021 | Apr 30, 2020 | $14.0K | Jul 29, 2021 |
| FY2020 | Apr 30, 2019 | $13.7K | Aug 13, 2020 |
| FY2018 | Apr 30, 2017 | $80.7K | Aug 13, 2018 |
| FY2017 | Apr 30, 2016 | $91.9K | Aug 15, 2017 |
| FY2012 | Apr 30, 2013 | ($1.1K) | Aug 14, 2013 |
| FY2012 | Apr 30, 2012 | ($1.1K) | Aug 14, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | ($37.3K) | Jul 29, 2025 |
| FY2025 | Apr 30, 2024 | ($396) | Jul 29, 2025 |
| FY2024 | Apr 30, 2023 | $76.6K | Aug 13, 2024 |
| FY2023 | Apr 30, 2022 | ($95.6K) | Aug 14, 2023 |
| FY2022 | Apr 30, 2021 | $2.2K | Jul 29, 2022 |
| FY2021 | Apr 30, 2020 | ($30.7K) | Jul 29, 2021 |
| FY2020 | Apr 30, 2019 | ($26.1K) | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | ($397.0K) | Aug 9, 2019 |
| FY2018 | Apr 30, 2017 | ($7.2K) | Aug 13, 2018 |
| FY2017 | Apr 30, 2016 | $34.5K | Aug 15, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | ($37.3K) | Jul 29, 2025 |
| FY2025 | Apr 30, 2024 | ($396) | Jul 29, 2025 |
| FY2024 | Apr 30, 2023 | $76.6K | Aug 13, 2024 |
| FY2023 | Apr 30, 2022 | ($95.6K) | Aug 14, 2023 |
| FY2022 | Apr 30, 2021 | $2.2K | Jul 29, 2022 |
| FY2021 | Apr 30, 2020 | ($30.7K) | Jul 29, 2021 |
| FY2020 | Apr 30, 2019 | ($26.1K) | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | ($408.3K) | Aug 9, 2019 |
| FY2018 | Apr 30, 2017 | ($23.4K) | Aug 13, 2018 |
| FY2017 | Apr 30, 2016 | $35.8K | Aug 15, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $0 | Jul 29, 2025 |
| FY2025 | Apr 30, 2024 | $0 | Jul 29, 2025 |
| FY2024 | Apr 30, 2023 | $0 | Aug 13, 2024 |
| FY2023 | Apr 30, 2022 | $0 | Aug 14, 2023 |
| FY2022 | Apr 30, 2021 | $0 | Jul 29, 2022 |
| FY2015 | Apr 30, 2015 | $0 | Aug 13, 2015 |
| FY2015 | Apr 30, 2014 | $0 | Aug 13, 2015 |
| FY2014 | Apr 30, 2013 | $0 | Aug 11, 2014 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | ($16.8K) | Jul 29, 2025 |
| FY2025 | Apr 30, 2024 | ($5.0K) | Jul 29, 2025 |
| FY2024 | Apr 30, 2023 | ($5.0K) | Aug 13, 2024 |
| FY2023 | Apr 30, 2022 | ($22.8K) | Aug 14, 2023 |
| FY2022 | Apr 30, 2021 | $14.4K | Jul 29, 2022 |
| FY2021 | Apr 30, 2020 | ($667) | Jul 29, 2021 |
| FY2020 | Apr 30, 2019 | $328 | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | ($2.0K) | Aug 9, 2019 |
| FY2018 | Apr 30, 2017 | ($166.1K) | Aug 13, 2018 |
| FY2017 | Apr 30, 2016 | ($173.6K) | Aug 15, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Apr 30, 2013 | ($28.6K) | Aug 14, 2013 |
| FY2012 | Apr 30, 2012 | ($28.6K) | Aug 14, 2012 |
| FY2012 | Apr 30, 2011 | ($8.5K) | Aug 14, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $1.3K | Jul 29, 2025 |
| FY2025 | Apr 30, 2024 | $437 | Jul 29, 2025 |
| FY2024 | Apr 30, 2023 | $16.7K | Aug 13, 2024 |
| FY2023 | Apr 30, 2022 | $497 | Aug 14, 2023 |
| FY2022 | Apr 30, 2021 | $14.8K | Jul 29, 2022 |
| FY2021 | Apr 30, 2020 | $454 | Jul 29, 2021 |
| FY2020 | Apr 30, 2019 | $1.1K | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | $793 | Aug 9, 2019 |
| FY2018 | Apr 30, 2017 | $369.4K | Aug 13, 2018 |
| FY2017 | Apr 30, 2016 | $356.5K | Aug 15, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $139.2K | Jul 29, 2025 |
| FY2025 | Apr 30, 2024 | $101.0K | Jul 29, 2025 |
| FY2024 | Apr 30, 2023 | $116.9K | Aug 13, 2024 |
| FY2023 | Apr 30, 2022 | $177.3K | Aug 14, 2023 |
| FY2022 | Apr 30, 2021 | $96.0K | Jul 29, 2022 |
| FY2021 | Apr 30, 2020 | $83.9K | Jul 29, 2021 |
| FY2020 | Apr 30, 2019 | $53.9K | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | $30.6K | Aug 9, 2019 |
| FY2018 | Apr 30, 2017 | $24.0K | Aug 13, 2018 |
| FY2017 | Apr 30, 2016 | $168.1K | Aug 15, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | ($137.9K) | Jul 29, 2025 |
| FY2025 | Apr 30, 2024 | ($100.6K) | Jul 29, 2025 |
| FY2025 | Apr 30, 2023 | ($100.2K) | Jul 29, 2025 |
| FY2024 | Apr 30, 2022 | ($176.8K) | Aug 13, 2024 |
| FY2023 | Apr 30, 2021 | ($81.2K) | Aug 14, 2023 |
| FY2022 | Apr 30, 2020 | ($83.4K) | Jul 29, 2022 |
| FY2021 | Apr 30, 2019 | ($52.8K) | Jul 29, 2021 |
| FY2020 | Apr 30, 2018 | ($29.8K) | Aug 13, 2020 |
| FY2019 | Apr 30, 2017 | $345.4K | Aug 9, 2019 |
| FY2018 | Apr 30, 2016 | $188.4K | Aug 13, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | ($1.11M) | Jul 29, 2025 |
| FY2025 | Apr 30, 2024 | ($1.07M) | Jul 29, 2025 |
| FY2024 | Apr 30, 2023 | ($1.07M) | Aug 13, 2024 |
| FY2023 | Apr 30, 2022 | ($1.15M) | Aug 14, 2023 |
| FY2022 | Apr 30, 2021 | ($1.05M) | Jul 29, 2022 |
| FY2021 | Apr 30, 2020 | ($1.06M) | Jul 29, 2021 |
| FY2020 | Apr 30, 2019 | ($1.02M) | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | ($998.7K) | Aug 9, 2019 |
| FY2018 | Apr 30, 2017 | ($601.7K) | Aug 13, 2018 |
| FY2017 | Apr 30, 2016 | ($594.5K) | Aug 15, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | $1.3K | Jul 29, 2025 |
| FY2025 | Apr 30, 2024 | $437 | Jul 29, 2025 |
| FY2024 | Apr 30, 2023 | $9.2K | Aug 13, 2024 |
| FY2023 | Apr 30, 2022 | $198 | Aug 14, 2023 |
| FY2022 | Apr 30, 2021 | $14.5K | Jul 29, 2022 |
| FY2021 | Apr 30, 2020 | $155 | Jul 29, 2021 |
| FY2020 | Apr 30, 2019 | $822 | Aug 13, 2020 |
| FY2019 | Apr 30, 2018 | $494 | Aug 9, 2019 |
| FY2018 | Apr 30, 2017 | $2.5K | Aug 13, 2018 |
| FY2018 | Apr 30, 2016 | $25.3K | Aug 13, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Apr 30, 2012 | $7.3K | Aug 14, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 0 | Jul 29, 2025 |
| FY2025 | Apr 30, 2024 | 0 | Jul 29, 2025 |
| FY2024 | Apr 30, 2023 | 0 | Aug 13, 2024 |
| FY2023 | Apr 30, 2022 | 0 | Aug 14, 2023 |
| FY2022 | Apr 30, 2021 | 0 | Jul 29, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 0 | Jul 29, 2025 |
| FY2025 | Apr 30, 2024 | 0 | Jul 29, 2025 |
| FY2024 | Apr 30, 2023 | 0 | Aug 13, 2024 |
| FY2023 | Apr 30, 2022 | 0 | Aug 14, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Apr 30, 2025 | 138.96M | Jul 29, 2025 |
| FY2025 | Apr 30, 2024 | 138.96M | Jul 29, 2025 |
| FY2024 | Apr 30, 2023 | 138.96M | Aug 13, 2024 |
| FY2023 | Apr 30, 2022 | 138.96M | Aug 14, 2023 |
| FY2022 | Apr 30, 2021 | 138.96M | Jul 29, 2022 |
| FY2021 | Apr 30, 2020 | 138.96M | Jul 29, 2021 |
| FY2021 | Apr 30, 2019 | 138.96M | Jul 29, 2021 |
| FY2019 | Apr 30, 2018 | 138.96M | Aug 9, 2019 |
| FY2018 | Apr 30, 2017 | 138.96M | Aug 13, 2018 |
| FY2017 | Apr 30, 2016 | 158.21M | Aug 15, 2017 |